|

CART19 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Children's Hospital of Philadelphia1

Indications

  • CART191
  • Lupus Nephritis (LN)1
  • SLE1
  • Systemic Lupus Erythematosus (SLE)1
  • Car T- Cell1

Philadelphia, Pennsylvania1 trial

CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus

Children's Hospital of Philadelphia

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.